PROSTATE CANCER FOUNDATION

Pcf created the young investigator award program with one goal: to build a gifted cohort of human capital supporting the next generation of prostate cancer researchers. Awards are made to early-career scientists working in a research environment capable of supporting high-impact prostate cancer research, drawn from a variety of medical research disciplines. In its 27th year, the pcf program has awarded nearly $93 million to advance the careers of 435 pcf young investigators, ensuring a continued stream of human capital into our research community. The pcf young investigator program plays an integral role in championing, mentoring, and identifying future medical research program leaders.

More than 12,000 men cared for by the department of veterans affairs (va) hospitals are newly diagnosed with prostate cancer each year, making it the most frequently diagnosed cancer among veterans. The pcf-va partnership is expanding research into prostate cancer precision oncology treatment options. The collaboration is expanding the number of precision oncology clinical studies conducted at veterans health administration hospitals, ensuring that eligible veterans can access and participate in these studies. The va's precision oncology program for cancer of the prostate (popcap) was established in partnership with the prostate cancer foundation 2016. The program uses genetic testing to find the best possible treatments for veterans with advanced prostate cancer. Popcap's network extends across the u.s. It includes 21 precision oncology centers of excellence, supplemented by regional centers, that provide cancer care to any veteran who develops prostate cancer, no matter where he lives.